Come meet Johnson & Johnson Innovation!

April 14, 2021

[ad_1]

Present throughout the world, Johnson & Johnson Innovation is calling on the innovation ecosystem in France with an online event on May 26 and 27: “Meet With Johnson & Johnson Innovation in France”. Discovery.

To develop innovative and sustainable solutions, pharmaceutical companies are increasingly turning to open innovation or open innovation. New illustration with Johnson & Johnson Innovation whose objective is to meet its industrial needs and those of innovative entrepreneurs.

Johnson & Johnson Innovation is now present throughout the world and offers different types of structures to bring out innovative solutions and collaborations with players in healthcare innovation:

  • Innovation Centers (Early Stage Acceleration): 4 innovation centers are present on 3 continents to create connections with innovation ecosystems all over the planet. More than 580 partnerships have been concluded over the past 6 years.

  • JJDC (Strategic Investors): investment fund to support the development of innovative companies

  • JLABS (Life Science Incubators): 13 incubation sites around the world with more than 700 companies supported

  • Business Development : Focuses on mid-stage and late-stage collaborations with established pharmaceutical, medical device and consumer health companies to accelerate disruptive innovations to address unmet medical needs and create real value in businesses. Johnson & Johnson priority areas: acquisition of assets, businesses and technologies, or entering into strategic collaborations, licenses and business partnerships.

“Innovation at Johnson & Johnson is about creating strong networks of people who can combine resources, ideas and technology in new ways. Says Paul Stoffels, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson.

Johnson & Johnson Innovation: a model of co-creation

Come and talk to the experts at Johnson & Johnson!

To meet the health innovation ecosystem in France, Johnson & Johnson Innovation is organizing a virtual event on May 26 and 27: “Meet With Johnson & Johnson Innovation in France”.

To introduce this event, present Johnson & Johnson Innovation and its activities in France, a webinar is organized on May 26 from 10:30 am to 12 noon with the interventions of:

  • Siau Bai, New Ventures Lead, Johnson & Johnson Innovation

  • Emmanuelle Quilès, Managing Director, Janssen France

  • Nerida Scott, Head, Johnson & Johnson Innovation EMEA

  • Elena Fernandez-Kleinlein, Head, JLABS EMEA, Johnson & Johnson Innovation

Throughout the afternoon of May 26 and the day of May 27, Johnson & Johnson Innovation offers one-to-one meetings with its experts to identify potential collaborations and projects.

You have until April 21 to register and meet the Johnson & Johnson Innovation experts

Johnson & Johnson Innovation is looking for partnerships in certain priority areas but if you offer a disruptive solution in an area not listed, you are encouraged to participate

About Johnson & Johnson Innovation

Johnson & Johnson Innovation Ltd is focused on accelerating all stages of innovation around the world and building collaborations between entrepreneurs and Johnson & Johnson. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with unique access to science and technology experts who can facilitate collaborations between Johnson & Johnson’s pharmaceutical, medical device and consumer health companies.

Under the aegis of Johnson & Johnson Innovation, through our innovation centers, JLABS, JJDC and J&J teams around the world, we are in contact with startups, biotechs, private research institutes and audiences and academics in order to create personalized agreements and unprecedented collaborations that accelerate the development of innovations aimed at meeting the unmet needs of patients. For more information on Johnson & Johnson Innovation, we invite you to visit the website www.jnjinnovation.com.

Post produced in partnership with Johnson & Johnson Innovation

Similar articles

[ad_2]